Natalia Buza, MD, Named First Director of New Yale Pathology Center of Excellence for Women’s Health
Natalia Buza, MD, Professor of Pathology and Associate Director of Gynecologic Pathology, has been appointed the first Director of the new Yale Pathology Center of Excellence for Women’s Health.
- October 04, 2022
Newly published research from Yale Pathology substantiates the impact of the drug aducanumab in reducing a plaque that is a defining pathologic feature of Alzheimer’s disease.
- September 30, 2022
Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine LearningSource: Journal of Clinical Oncology
In this study, we use a Machine Learning algorithm for prediction of adverse outcomes at radical prostatectomy using whole-slide images of prostate biopsies with Grade Group 2 or 3 disease.
- September 23, 2022
Keith Choate, MD, PhD, will become chair of the Department of Dermatology and chief of Dermatology of Yale New Haven Hospital effective October 1, 2022. Choate will also work collaboratively with delivery network leadership to advance dermatological services across Yale New Haven Health System.
- September 22, 2022
De Qué Trata la Inmunoterapia, un Tratamiento Que ha Mostrado Grandes Avances en la Lucha Contra el CáncerSource: UNIVISION
Este 22 de septiembre el Instituto de Investigación del Cáncer en Estados Unidos llevará a cabo una conferencia virtual en la que abordará varios temas sobre la inmunoterapia y sus beneficios para los pacientes con cáncer. De acuerdo con Kurt Schalper, profesor de la Universidad de Yale, el objetivo de dicha reunión es lograr que la comunidad hispana tenga acceso a información valiosa acerca de dicho tratamiento. | This September 22, the Institute for Cancer Research in the United States will hold a virtual conference in which it will address various topics about immunotherapy and its benefits for cancer patients. According to Kurt Schalper, a professor at Yale University, the objective of this meeting is to ensure that the Hispanic community has access to valuable information about said treatment.
- September 20, 2022
ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology
Madeline Mayday, BS, a fourth-year Experimental Pathology graduate student in the Laboratory of Diane Krause, MD, PhD, was recently awarded a 2022 National Institute of Diabetes and Digestive and Kidney Diseases Hematology Centers Program Type B Pilot and Feasibility grant
- September 19, 2022
Arnaud Augert, PhD, Assistant Professor of Pathology at Yale School of Medicine and member of Yale Cancer Center, has been named a V Scholar by the V Foundation for Cancer Research. The V Foundation supports young tenure-track faculty by funding laboratory-based fundamental research or translational research.
- September 13, 2022
Q&A with Pei Hui, PhD, MD, a surgical pathologist, in recognition of Gynecologic Cancer Awareness Month.
- September 12, 2022
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named by the American Joint Committee on Cancer (AJCC) to its editorial board for neuroendocrine tumors of the gastrointestinal tract.
- September 06, 2022
Marie Robert, MD, Jordan Pober, MD, PhD, Awarded POINTS Grant to Study Pathogenesis of Celiac Disease
Marie Robert, MD, Professor of Pathology and of Medicine (Digestive Diseases), and Jordan Pober, MD, PhD, the Bayer Professor of Translational Medicine and Professor of Immunobiology, Pathology, and Dermatology, have been awarded a grant from the Program for the Promotion of Interdisciplinary Team Science (POINTS) at Yale School of Medicine to study the Pathogenesis of Celiac Disease.